Different patterns of apoptosis in response to cisplatin in B50 neuroblastoma rat cells

Histology and Histopathology

Volumn 26, Issue 7, 2011, Pages 831-842

  Santin, G ^a   Piccolini, V M ^a   Veneroni, P ^a   Barni, S ^a   Bernocchi, G ^a   Bottone, M G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Apoptosis; B50 neuroblastoma rat cells; Cisplatin; Endoplasmic reticulum; Mitochondria

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; CASP3 PROTEIN, RAT; CASPASE 3; CISPLATIN; PDCD8 PROTEIN, RAT;

ANIMAL; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; DRUG EFFECT; ENDOPLASMIC RETICULUM; FLUORESCENCE MICROSCOPY; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROBLASTOMA; PATHOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; CASPASE 3; CELL LINE, TUMOR; CISPLATIN; ENDOPLASMIC RETICULUM; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NEUROBLASTOMA; RATS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

RATTUS;

EID: 79960695432     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Abraham M.C. and Shaham S. (2004). Death without caspases, caspases without death. Trends Cell Biol. 14, 184-193.
2. Adams J.M. (2003). Ways of dying: multiple pathways to apoptosis. Genes Dev. 17, 2481-2495.
3. Barnhart B.C., Lee J.C., Alappat E.C. and Peter M.E. (2003). The death effector domain protein family. Oncogene 22, 8634-8644.
4. Bodenner D.L., Dedon P.C., Keng P.C., Katz J.C. and Borch R.F. (1986). Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate. Cancer Res. 46, 2751-2755.
5. Bottone M.G., Soldani C., Veneroni P., Avella D., Pisu M. and Bernocchi G. (2008). Cell proliferation, apoptosis and mitochondrial damage in rat B50 neuronal cells after cisplatin treatment. Cell Prolif. 41, 506-520.
6. Bottone M.G., Soldani C., Fraschini A., Croce A.C., Bottiroli G., Camboni T., Scovassi A.I. and Pellicciari C. (2009). Enzymeassisted photosensitization activates different apoptotic pathways in Rose Bengal acetate treated Hela cells. Histochem. Cell Biol. 131, 391-399.
7. Bottone M.G., Giansanti V., Veneroni P, Scovassi A.I., Bernocchi G. and Pellicciari C. (2010). The apoptosis-inducing factor (AIF) moves from mitochondria to the nucleus and back to the cytoplasm, during apoptosis. In: Mitochondria: Structure, functions and dysfunctions. Svensson O.L. (ed). Nova Science Publishers, Inc. pp 11788-3619.
8. Camins A., Pallas M. and Silvestre J.S. (2008). Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches. Methods Find. Exp. Clin. Pharmacol. 30, 43-65.
9. Cece R., Barajon I. and Tredici G. (1995). Cisplatin induces apoptosis in SH-SY5Y human neuroblastoma cell line. Anticancer Res. 15, 777-782.
10. Dietrich J., Han R., Yang Y., Mayer-Pröschel M. and Noble M. (2006). CNS progenitor cells and oligodendrocytes are target of chemotherapeutic agents in vitro and in vivo. J. Biol. 5, 22.
11. Ferri K.F. and Kroemer G. (2001). Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3, 255-263.
12. Fisher D.E. (1994). Apoptosis in cancer therapy: Crossing the threshold. Cell 78, 539-542.
13. Fulda S. (2008). Caspase-8. In: Encyclopedia of cancer. Schwab M. (ed). Springer. Berlin.
14. Fulda S. (2009). Caspase-8 in cancer biology and therapy. Cancer Lett. 281, 128-133.
15. Kaufmann S.H. (2007). The intrinsic pathway of apoptosis. In: Apoptosis, senescence, and cancer. Gewirtz D.A., Grant S. and Holt S.E. (eds). Humana Press. pp 3-30.
16. Kim J.S., Lee J.M., Chwae Y-J., Kim Y.H., Lee J.H., Kim K., Lee T.H., Kim S.J. and Park J.H. (2003). Cisplatin-induced apoptosis in Hep3B cells: mitochondria-dependent and independent pathways. Biochem. Pharmacol. 67, 1459-1468.
17. Kruiderin G. and Evan G.I. (2000). Caspase-8 in Apoptosis: The Beginning of "The End"?. IUBMB Life 50, 85-90
18. Lindholm D., Wootz H. and Korhonen L. (2006). ER stress and neurodegenerative diseases. Cell Death Differ. 13, 385-392.
19. Lipton S.A. and Bossy-Wetzel E. (2002). Dueling activities of AIF in cell death versus survival: DNA binding and redox activity. Cell 111, 147-150.
20. Liu X., Kim C.N., Yang J., Jemmerson R. and Wang X. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157.
21. Modjtahedi N., Giordanetto F., Madeo F. and Kroemer G. (2006). Apoptosis inducing factor: vital and lethal. Trends Cell Biol. 16, 264-272.
22. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A. and Yuan J. (2000). Caspase-12 mediates endoplasmic-reticulumspecific apoptosis and cytotoxicity by amyloid-beta. Nature 403, 98-103.
23. Park M.S., De Leon M. and Devarajan P. (2002). Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J. Am. Soc. Nephrol. 13, 858-865.
24. Perier C., Bové J., Dehay B., Jackson-Lewis V., Rabinovitch P.S., Przedborski S. and Vila M. (2010). Apoptosis-inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins. Ann. Neurol. 68, 184-192.
25. Rao R.V., Ellerby H.M. and Bredesen D.E. (2004). Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ. 11, 372-380.
26. Rosenberg B. (1999). Platinum complexes for the treatment of cancer: Why the search goes on, in Cisplatin. In: Chemistry and biochemistry of a leading anticancer drug. Lippert B. (ed). Wiley-VCH. Basel. pp 3-27.
27. Scovassi A.I., Soldani C., Veneroni P., Bottone M.G. and Pellicciari C. (2009). Changes of mitochondria and relocation of the apoptosisinducing factor during apoptosis. Ann. NY Acad. Sci. 1171, 12-17.
28. Susin S.A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M. and Kroemer G. (1996). Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184, 1331-1342.
29. Zhang Y., Zhang C., Narayani N., Du C. and Balaji K.C. (2007). Nuclear translocation of apoptosis inducing factor is associated with cisplatin induced apoptosis in LNCaP prostate cancer cells. Cancer Lett. 255, 127-134.